Navigator Global

China NMPA releases GCP for Drugs (2025) draft revision: Key changes and 2020 GCP comparison

The draft aims to strengthen trial participant protection, improve data integrity and clarify sponsor and investigator responsibilities across a streamlined structure of six chapters covering the full trial lifecycle

Cisema
News | 5 minutes | 14 Nov, 2025
  • Product Compliance
  • Pharma
  • China
2360088501-desktop

Get all the global insights to take your business anywhere.

  • Access our network of verified global experts and services.
  • Get the latest trade intelligence and networking opportunities.
  • Expand quickly with our step-by-step Action Plans.

Level up now. You’ll soon have the contacts, confidence and coaching to navigate new markets, so every step feels like the right one.


Already registered? Log in